Nucleocapsid protein enhances spike- and RBD-specific humoral and cellular immune responses in protein-based SARS-CoV-2 vaccine. - Gröhn S; Lehto H; Soppela S; Naves RA; Ritvos MA; Iakubovskaia A; Lampinen V; Mustonen I; Pakkala S; Husu E; Kakkola L; Julkunen I; et al. (BMC infectious diseases, 2026)